Canada Plasma Fractionation Market Size, Share & Industry Analysis, By Product (Albumin, Immunoglobulin [Intravenous Immunoglobulin {IVIG}, and Subcutaneous Immunoglobulin {SCIG}], Coagulation Factors [Factor IX, Factor VIII, Prothrombin Complex Concentrates, Fibrinogen Concentrates, and Others], Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End User (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Country Forecast, 2025-2032

Last Updated: December 31, 2025 | Format: PDF | Report ID: FBI114990

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Growth Takeaways in the Market
2. Overview: Evolution of Human Fibrinogen Concentrate Therapies in Canada
3. Key Industry Development- Mergers, Acquisitions, Partnerships, Others
4. New Product Launches, By Key Players
Canada Plasma Fractionation Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Albumin
  2. Immunoglobulin
    1. Intravenous Immunoglobulin
    2. Subcutaneous Immunoglobulin
  3. Coagulation Factors
    1. Factor IX
    2. Factor VIII
    3. Prothrombin Complex Concentrates
    4. Fibrinogen Concentrates
    5. Others
  4. Protease Inhibitors
  5. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Immunology & Neurology
  2. Hematology
  3. Critical Care
  4. Pulmonology
  5. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Research Laboratories
  3. Others
Competitive Analysis
1. Canada Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Octapharma AG
  2. CSL Behring LLC.
  3. Grifols S.A.
  4. Takeda Pharmaceutical Company Limited
  5. Other Prominent Players

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Growth Takeaways in the Market
2. Overview: Evolution of Human Fibrinogen Concentrate Therapies in Canada
3. Key Industry Development- Mergers, Acquisitions, Partnerships, Others
4. New Product Launches, By Key Players
Canada Plasma Fractionation Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Albumin
  2. Immunoglobulin
    1. Intravenous Immunoglobulin
    2. Subcutaneous Immunoglobulin
  3. Coagulation Factors
    1. Factor IX
    2. Factor VIII
    3. Prothrombin Complex Concentrates
    4. Fibrinogen Concentrates
    5. Others
  4. Protease Inhibitors
  5. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Immunology & Neurology
  2. Hematology
  3. Critical Care
  4. Pulmonology
  5. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Research Laboratories
  3. Others
Competitive Analysis
1. Canada Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Octapharma AG
  2. CSL Behring LLC.
  3. Grifols S.A.
  4. Takeda Pharmaceutical Company Limited
  5. Other Prominent Players

Read Less

Figure 01: Canada Plasma Fractionation Market Revenue Breakdown (USD billion, %) by Product, 2024 & 2032

Figure 02: Canada Plasma Fractionation Market Value Share (%), by Product, 2024 & 2032

Figure 03: Canada Plasma Fractionation Market Value Share (%), by Application, 2024 & 2032

Figure 04: Canada Plasma Fractionation Market Value Share (%), by End User, 2024 & 2032

Figure 05: Canada Plasma Fractionation Market Share (%), by Company, 2024

Table 01: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 02: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2019–2032

Table 03: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2019–2032

Table 04: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 05: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2019–2032

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us